Pharmaceutical Executive
April 07, 2011
0
0
In France, it took a president's keynote speech to underscore the government's new understanding that there is more to pharmaceuticals than cost-containment
July 01, 2010
0
0
Focus Reports discusses kep questions regarding France's pharma industry
July 01, 2010
Features
0
0
FDA's risk-reduction requirements could be the bridge to a bright new future for the pharma industry.
July 01, 2010
Europe Report
0
0
As they build market share, companies need a plan to limit exposure to steep fines and executive prosecutions.
July 01, 2010
Features
0
0
Outsourcing the sales representative function can help pharmaceutical companies build on their bottom line.
July 01, 2010
Washington Report
0
0
Drug prices, doctor payments, and FDA regulatory decisions are candidates for expanded disclosure.
July 01, 2010
Leadership
0
0
Once occupied by a single pharma leader, the roles of CEO, president, and board chairman are increasingly being separated. What's behind the trend?
July 01, 2010
Columns
0
0
New strategies like augmented reality can increase patient compliance and knowledge.
July 01, 2010
Features
0
0
Pharma companies are starting to get back in the game with increased advertising spend in 2009. Do we have economic recovery to thank, or is there a deeper cause?
July 01, 2010
From the Editor
0
0
If there was ever a justification for endorsing a "triple bottom line" strategy for measuring Big Pharma's investment performance, it's the BP crisis.
July 01, 2010
Columns
0
0
Why pharma sales representatives are still the best marketers and how to make them better.